Poison Centers Detect an Unexpectedly Frequent Number of Adverse Drug Reactions to Lisdexamfetamine
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Bronstein, A. C., Spyker, D. A., Cantilena, L. R., Green, J., Rumack, B. H., & Heard, S. E. (2007) · Clinical Toxicology · doi:10.1080/15563650701754763 · Cited by 336 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A Systematic Review of the Safety of Lisdexamfetamine Dimesylate
Coghill, D. R., Caballero, B., Sorooshian, S., & Civil, R. (2014) · CNS Drugs · doi:10.1007/s40263-014-0166-2 · Cited by 89 · see citing works
The Value and Evolving Role of the U.S. Poison Control Center System
Spiller, H. A., & Griffith, J. R. K. (2009) · Public Health Reports · doi:10.1177/003335490912400303 · Cited by 61 · see citing works
Self-citationNajib, J. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.01.015 · Cited by 40 · see citing works
Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers
Kaland, M. E., & Klein‐Schwartz, W. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1027903 · Cited by 39 · see citing works
Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
Najib, J., Wimer, D., Zeng, J., Lam, K. W., Romanyak, N., Paige Morgan, E., & Thadavila, A. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517728090 · Cited by 17 · see citing works
Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD
Dew, R. E., & Kollins, S. H. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.531009 · Cited by 14 · see citing works
Lisdexamfetamine for Treatment of Attention-Deficit/Hyperactivity Disorder
Cowles, B. J. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l521 · Cited by 14 · see citing works
Najib, J. S., Didenko, E., Meleshkina, D., Yusupov, K., Maw, K., Ramnarain, J., & Tabassum, M. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1815002 · Cited by 12 · see citing works
Madaan, V., & Domnitei (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3328 · Cited by 12 · see citing works
Alopecia Following Initiation of Lisdexamfetamine in a Pediatric Patient
Brahm, N. C., & Hamilton, D. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08l00753 · Cited by 9 · see citing works
Najib, J. (2012) · Adolescent Health, Medicine and Therapeutics · doi:10.2147/ahmt.s19815 · Cited by 8 · see citing works
Cowles, B. J. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s6733 · Cited by 6 · see citing works
Adverse events related to medications identified by a Canadian poison centre.
Ackroyd-Stolarz, S. A., MacKinnon, N. J., Murphy, N. G., Gillespie, E., & Zed, P. J. (2011) · PubMed · Cited by 4 · see citing works
Potter, P. O., John, N. J., & Coffey, D. B. J. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.2253 · Cited by 3 · see citing works
Toxicology services in Libya: the present and the future
Saleh, R., & Kamour, A. M. (2014) · Libyan Journal of Medicine · doi:10.3402/ljm.v9.24292
Pattern of Lisdexamfetamine Ingestions Reported to Texas Poison Centers
Forrester, M. B. (2009) · Journal of Pharmacy Technology · doi:10.1177/875512250902500103
Current awareness: Pharmacoepidemiology and drug safety
(2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1644
- Authors
- Spiller, H. A., Griffith, J. R., Anderson, D. L., Weber, J. A., & Aleguas, A.
- Affiliations
- Kentucky Regional Poison Center PO Box 35070 Louisville, Kentucky 40232
- Clinical Pharmacist Central Ohio Poison Center Columbus, Ohio
- Hennepin Regional Poison Center Minneapolis, Minnesota
- Missouri Regional Poison Center Saint Louis, Missouri
- Clinical Manager Regional Poison Center Serving Massachusetts and Rhode Island Boston, Massachusetts
- Corresponding author
- Spiller, Henry A
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2008-05-27
- Volume
- 42
- Issue
- 7-8
- Pages
- 1142-1143
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W1977388990
- Cited by
- 17
- References
- 1
- Citations by year
- 2020: 1 · 2017: 1 · 2015: 1 · 2014: 2 · 2012: 2
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- lisdexamfetamine, adverse drug reactions, poison control centers, drug safety, stimulants, ADHD medication
- MeSH terms
- Lisdexamfetamine Dimesylate, Adolescent, Adult, Central Nervous System Stimulants, Child, Child, Preschool, Dextroamphetamine, Humans, Poison Control Centers, Retrospective Studies, United States, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
